Table 3.
Disease progression and management.
| Item | Country | No. Respondents | Mean | SD | No. Responding ‘Yes’ | % | 95% Confidence Interval (%) |
|---|---|---|---|---|---|---|---|
| No. symptoms | Italy | 88 | 11.0 | 3.0 | 10.4–11.6 | ||
| Latvia | 75 | 7.5 | 2.5 | 6.9–8.1 | |||
| UK | 445 | 8.0 | 4.1 | 7.6–8.4 | |||
| Treatments: | |||||||
| - All | Italy | 88 | 0.5 | 0.2 | 0.33–0.67 | ||
| Latvia | 75 | 2.5 | 1.2 | 2.2–2.8 | |||
| UK | 425 | 3.0 | 3.0 | 2.7–3.3 | |||
| - Drug treatment | Italy | 88 | 0.5 | 0.2 | 0.33–0.67 | ||
| Latvia | 75 | 2.3 | 1.3 | 2.0–2.6 | |||
| UK | 425 | 1.3 | 4.0 | 0.9–1.7 | |||
| - Non-drug treatment | Italy | - | - | - | - | ||
| Latvia | 75 | 1.2 | 1.0 | 1.0–1.4 | |||
| UK | 425 | 1.7 | 2.1 | 1.5–1.9 | |||
| No. investigations | Italy | 88 | 10.4 | 2.4 | 9.9–10.9 | ||
| Latvia | 75 | 5.7 | 3.2 | 5.0–6.4 | |||
| UK | 178 | 12.8 | 29.0 | 8.5–17.0 | |||
| No. respondents reporting: | |||||||
| >10 investigations | Italy | 88 | 65 | 73.9 | 63.0–84.8 | ||
| Latvia | 75 | 3 | 4.0 | 0.0–26.6 | |||
| UK | 178 | 86 | 48.3 | 37.5–59.1 | |||
| >10 symptoms | Italy | 88 | 64 | 72.7 | |||
| Latvia | 75 | 7 | 9.3 | 4.6–18.0 | |||
| UK | 445 | 86 | 19.3 | 1.8–27.8 | |||
| >5 treatments | Italy | 88 | 29 | 32.9 | 24.0–43.3 | ||
| Latvia | 75 | 0 | 0.0 | - | |||
| UK | 425 | 63 | 14.8 | 5.9–23.8 | |||
| Variability of symptoms | Italy | 86 | 48 | 55.8 | 41.5–70.1 | ||
| Latvia | 75 | 53 | 70.7 | 58.2–83.2 | |||
| UK | 446 | 410 | 91.9 | 89.2–94.6 |